Janssen Research & Development Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data
5/16/2013 7:10:42 AM
More...
|
Janssen Research & Development Release: FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
5/13/2013 10:01:31 AM
More...
|
Janssen Research & Development Release: Ibrutinib Expanded Access Program Open to Eligible U.S. Patients With Relapsed or Refractory Mantle Cell Lymphoma
5/6/2013 9:58:50 AM
More...
|
Janssen Research & Development and Johnson & Johnson (JNJ) to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
5/3/2013 7:29:00 AM
More...
|
Janssen Research & Development Release: Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma From FDA
5/1/2013 10:59:56 AM
More...
|
Ascletis, Inc. Gains China Market Rights From Janssen Research & Development to a Clinical Stage HIV Protease Inhibitor
4/30/2013 10:55:32 AM
More...
|
Janssen Research & Development Release: INCIVO® Receives Positive Opinion From the Committee for Medicinal Products for Human Use (CHMP) for Twice Daily Dosing for Treatment of Genotype-1 Hepatitis C Virus
4/26/2013 10:08:08 AM
More...
|
Janssen Research & Development Release: Follow-up Data Show ZYTIGA® Plus Prednisone Continues to Delay Progression of Metastatic Castration-Resistant Prostate Cancer in Patients Without Prior Chemotherapy
2/13/2013 9:09:57 AM
More...
|
Janssen Research & Development Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
2/5/2013 10:08:08 AM
More...
|
Janssen Research & Development Release: The New England Journal of Medicine Publishes Efficacy Data for ZYTIGA® Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Not Received Chemotherapy
12/13/2012 9:29:22 AM
More...
|
|